Kazakhstan vs Lebanon: Cause of death, by non-communicable diseases, ages 5-14, male
Kazakhstan
35.4%
in 2021
Lebanon
35.3%
in 2021
Kazakhstan rank
91st
Lebanon rank
92nd
Cause of death, by non-communicable diseases, ages 5-14, male over time
- Kazakhstan
- Lebanon
How they compare
Kazakhstan currently reports 35.4% against 35.3% in Lebanon, a difference of 0.1%.
Across all 6 years both countries report, Kazakhstan has been ahead every year.
Kazakhstan ranks 91st and Lebanon ranks 92nd of 185 countries.
Kazakhstan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kazakhstan | Lebanon | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 30.1% | 24.4% | 5.6% | Kazakhstan |
| 2010s | 35.1% | 28.9% | 6.2% | Kazakhstan |
| 2020s | 36.9% | 34.2% | 2.6% | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, male, Kazakhstan or Lebanon?
- Kazakhstan, at 35.4% against 35.3% in Lebanon as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, male between Kazakhstan and Lebanon?
- 0.1%, with Kazakhstan ahead.
- How many years of comparable data are there for Kazakhstan and Lebanon?
- 6 years are reported by both, from 2000 to 2021.
- How do Kazakhstan and Lebanon rank globally for cause of death, by non-communicable diseases, ages 5-14, male?
- Kazakhstan ranks 91st and Lebanon ranks 92nd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.